135 filings
Page 3 of 7
8-K
7rxa q00qrbnog
24 Sep 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
12:00am
8-K
n32fu5ri0px
23 Sep 21
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
7:54am
8-K
zkezb0fx
30 Aug 21
Catalent, Inc. Reports Fourth Quarter Fiscal 2021 Results
7:15am
8-K
iw7i47j4 mm9
20 May 21
Departure of Directors or Certain Officers
4:33pm
8-K
otnjoq9t
11 May 21
Departure of Directors or Certain Officers
7:30am
8-K
ja2921i spuwzm0p
4 May 21
Catalent, Inc. Reports Third Quarter Fiscal 2021 Results
7:07am
8-K
xz2y9atmdb
22 Feb 21
Entry into a Material Definitive Agreement
4:27pm
8-K
v089bh07iqsrk
10 Feb 21
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
5:29pm
8-K
3t6wnhj39lkq
10 Feb 21
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
7:50am
8-K
ozwbja7
2 Feb 21
Catalent, Inc. Reports Second Quarter Fiscal 2021 Results
7:21am
8-K
on5lbr
3 Nov 20
Catalent, Inc. Reports First Quarter Fiscal 2021 Results
7:13am
8-K
csas201k
31 Aug 20
Catalent, Inc. Reports Fourth Quarter Fiscal 2020 Results
7:06am
8-K
xq2zjj 7564oxwjp8s
30 Jul 20
Results of Operations and Financial Condition
8:22am
8-K
v05vsspcfi
15 Jun 20
Entry into a Material Definitive Agreement
4:20pm
8-K
eknngzcpkxx lnxv
11 Jun 20
Catalent, Inc. Announces Pricing of Public Offering of Common Stock
8:52am
8-K
5hikmpz cqw
10 Jun 20
Catalent, Inc. Announces Public Offering of Common Stock
4:19pm
8-K
eagvfeazw
5 May 20
Catalent, Inc. Reports Third Quarter Fiscal 2020 Results
7:32am
8-K
nyqleis
30 Apr 20
Catalent Announces Next Generation of Cell & Gene Therapy Leadership
4:43pm
8-K
wcc3rcbi2i 3qc2
3 Mar 20
Entry into a Material Definitive Agreement
4:16pm
8-K
3treg ix4zchnykp256
20 Feb 20
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2028
4:28pm